Welcome to the Journal
Journal of Diabetes Medication & Care a field of study has been gaining great significance with the increasing financial burden to the nations of the globe. Diabetes is the number one reason for deaths globally.Journal of Diabetes Medication & Care is a scholarly open access journal that offers an Open Access platform to the scholars, professors, clinical practitioners and students that are keen in contributing their findings in this field.
Since Journal of Diabetes Medication & Care can be prevented by addressing behavioural risk factors Journal of Diabetes Medication & Care journal includes wide areas of studies in this field by including Diabetes Complications, Gestational Diabetes, Contemporary Researches on Diabetes, Nutritional dietes, Excercise, Metabolism, Diabetes Distress, Genetic Diabetes, Neurogenic Diabetic problems, etc.
The journal offers thoroughly reviewed original research as research articles, review articles, case studies, commentaries, Short Communication, and Letters to the Editors in the areas not limited to association of abiotrophia species with heart problem, heart and blood vessel disorders, myocardial infarction (heart attack), issues of cardiac arrest, stroke, techniques and procedure used in stent implantation, anticoagulant drugs (blood thinners), basic research in heart structure and functions and other medical conditions and associated treatments etc.
The journal also focuses on the latest therapeutic efforts such as application of cardiac progenitor cells, angioplasty, percutaneous coronary intervention (PCI) such as percutaneous transluminal coronary angioplasty (PTCA), and other stent implantation, anticoagulant drugs (blood thinners), therapy after open heart surgery, use of ventricular assist device.
Journal of Diabetes Medication & Care is listed in the quality indexing sites such as Scopus, EMBASE/Excerpta Medica to increase visibility and discoverability.
Fast Editorial Execution and Review Process (FEE-Review Process):
Journal of Diabetes Medication & Care is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.
Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.
The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.
Recently Published Articles
Short Communication p. 01-03
Author(s): Jaggy S
Diabetes Technology has ushered in a new era of diabetes management, providing innovative solutions to improve glycemic control and enhance the quality of life for individuals living with di..
Editorial p. 01-03
Author(s): Rahul Gupta
Medications can play a significant role in the management of prediabetes, a condition characterized by higher than normal blood sugar levels that are not yet high enough to be classified as ..
Editorial p. 01-03
Author(s): James F
Diabetes, a global silent epidemic, affects millions worldwide with an estimated 463 million adults impacted in 2019. This article provides a concise overview of diabetes, including its prev..
Mini Review p. 01-04
Author(s): Tom D
Gestational diabetes mellitus (GDM) is a transient condition affecting pregnant women globally, characterized by elevated blood glucose levels. This article provides a concise overview of GD..